Eleven Bio To Report Second Quarter 2017 Financial Results On Monday, August 14, 2017 Post author:Sam Post published:August 6, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Price of Teva's Generic Drug to Treat Wilson’s Disease Sparks Outrage February 25, 2018 IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017 Achaogen Announces Leadership Promotions February 23, 2017
IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain February 2, 2017